Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4070/kcj.2018.0103 http://scihub22266oqcxt.onion/10.4070/kcj.2018.0103 C5940640!5940640!29737639     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29737639.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Korean+Circ+J 2018 ; 48 (5): 337-49 Nephropedia Template TP {{tp|p=29737639|t=2018. Current Management of In-Stent Restenosis |pdf=|usr=}}{{29737639}} gab.com Text Current Management of In-Stent Restenosis JO: Korean Circ J http://www.kidney.de/pget.php?&tw=1&pmid=29737639 #FOAvip Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons. Several recent studies have compared the available options for treating ISR in an attempt to identify the preferred therapeutic strategy. In this review, we will discuss the currently available therapeutic strategies for the management of patients with ISR and the evidence supporting their use. Twit Text FOAVip Current Management of In-Stent Restenosis ????Korean Circ J http://www.kidney.de/pget.php?&tw=1&pmid=29737639 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29737639 #FOAvip English Wikipedia <ref>{{Cite pmid|29737639}}</ref> Current Management of In-Stent Restenosis #MMPMID29737639 Her AY; Shin ES Korean Circ J 2018[May]; 48 (5): 337-49 PMID29737639show ga Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons. Several recent studies have compared the available options for treating ISR in an attempt to identify the preferred therapeutic strategy. In this review, we will discuss the currently available therapeutic strategies for the management of patients with ISR and the evidence supporting their use. äCurrent Management of In-Stent Restenosis (epmc).pdf DeepDyve Pubget Overpricing